Cargando…
Active removal of anterior segment-migrated dexamethasone implant (Ozurdex(®))
Background: Ozurdex(®) (Allergan plc., Dublin, Ireland) is an intravitreal sustained-release dexamethasone (DEX) implant. The implant has been reported to migrate into the anterior chamber, potentially causing corneal decompensation. Prompt removal or relocation in the vitreous cavity is advised but...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
German Medical Science GMS Publishing House
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006423/ https://www.ncbi.nlm.nih.gov/pubmed/35465301 http://dx.doi.org/10.3205/oc000195 |